EMDB/PDB/SASBDBから引用されている文献のデータベース

キーワード
構造解析手法	All X線回折 NMR 電子顕微鏡小角散乱中性子線回折線維回折粉末回折赤外分光 EPR FRET 理論モデルハイブリッド
著者・登録者
ジャーナル
IF	>30 >20 >10 >5 all

タイトル	Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors.
ジャーナル・号・ページ	Nat Commun, Vol. 12, Page 743-743, Year 2021
掲載日	2020年4月29日 (構造データの登録日)
著者	Osipiuk, J. / Azizi, S.A. / Dvorkin, S. / Endres, M. / Jedrzejczak, R. / Jones, K.A. / Kang, S. / Kathayat, R.S. / Kim, Y. / Lisnyak, V.G. ...Osipiuk, J. / Azizi, S.A. / Dvorkin, S. / Endres, M. / Jedrzejczak, R. / Jones, K.A. / Kang, S. / Kathayat, R.S. / Kim, Y. / Lisnyak, V.G. / Maki, S.L. / Nicolaescu, V. / Taylor, C.A. / Tesar, C. / Zhang, Y.A. / Zhou, Z. / Randall, G. / Michalska, K. / Snyder, S.A. / Dickinson, B.C. / Joachimiak, A.
リンク	Nat Commun / PubMed:33531496
手法	X線回折
解像度	1.6 - 2.48 Å
構造データ	PDB-6wrh: The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant 手法: X-RAY DIFFRACTION / 解像度: 1.6 Å PDB-6wzu: The crystal structure of Papain-Like Protease of SARS CoV-2 , P3221 space group 手法: X-RAY DIFFRACTION / 解像度: 1.79 Å PDB-6xg3: The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, at room temperature 手法: X-RAY DIFFRACTION / 解像度: 2.48 Å PDB-7jir: The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, in complex with PLP_Snyder457 inhibitor 手法: X-RAY DIFFRACTION / 解像度: 2.09 Å PDB-7jit: The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, in complex with PLP_Snyder495 inhibitor 手法: X-RAY DIFFRACTION / 解像度: 1.95 Å PDB-7jiv: The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, in complex with PLP_Snyder530 inhibitor 手法: X-RAY DIFFRACTION / 解像度: 2.05 Å PDB-7jiw: The crystal structure of Papain-Like Protease of SARS CoV-2 in complex with PLP_Snyder530 inhibitor 手法: X-RAY DIFFRACTION / 解像度: 2.3 Å
化合物	ChemComp-ZN: Unknown entry ChemComp-PO4: PHOSPHATE ION / ホスファ-ト ChemComp-CL: Unknown entry / クロリド ChemComp-GOL: GLYCEROL / グリセロ-ル ChemComp-HOH: WATER ChemComp-TTT: 5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide / GRL-0617 ChemComp-MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID / 2-モルホリノエタンスルホン酸 / pH緩衝剤YM ChemComp-ACT: ACETATE ION / 酢酸イオン ChemComp-Y95: 5-[(carbamoylcarbamoyl)amino]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide ChemComp-VBY*: 5-(acryloylamino)-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide
由来	severe acute respiratory syndrome coronavirus 2 (ウイルス)
キーワード	HYDROLASE / covid-19 / coronavirus / SARS / CoV-2 / papain-like protease / IDP51000 / Center for Structural Genomics of Infectious Diseases / CSGID / HYDROLASE/HYDROLASE inhibitor / HYDROLASE-HYDROLASE inhibitor complex